Dow Down 0.92% Nasdaq Down 0.83%

Celgene Corporation (CELG)

-NasdaqGS
94.76 Down 0.21(0.22%) Oct 22, 4:00PM EDT
|After Hours : 93.95 Down 0.81 (0.85%) Oct 22, 7:47PM EDT
Prev Close:94.97
Open:95.58
Bid:93.95 x 100
Ask:94.90 x 400
1y Target Est:104.48
Beta:1.5
Next Earnings Date:23-Oct-14CELG Earnings announcement
Day's Range:93.82 - 96.85
52wk Range:66.85 - 96.85
Volume:8,717,401
Avg Vol (3m):4,599,050
Market Cap:75.76B
P/E (ttm):54.77
EPS (ttm):1.73
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGDown 0.22%75.76B
JNJUp 0.86%285.47B

Key Statistics

Forward P/E (1 yr):19.42
P/S (ttm):10.80
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.67
Quarterly EPS Est (Sep-14) :0.95
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.97

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback